SCHEMBL8466852

SCHEMBL8466852

OCCC1CCCC1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8468098 0.95 CA1 (0.33) —
SCHEMBL10773607 0.81 CA1 (0.35) —
SCHEMBL2761850 0.76 SIGMAR1 (0.35) —
SCHEMBL13880873 0.76 — —
SCHEMBL349548 0.75 CA1 (0.40) —
SCHEMBL7126992 0.75 CA1 (0.40) —
SCHEMBL8465260 0.75 — —
SCHEMBL11834380 0.72 CA1 (0.30) —
SCHEMBL20569827 0.72 — —
SCHEMBL7215764 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5869471-A Methods for the treatment of arthritis using phosphonates and NSAIDS THE PROCTOR & GAMBLE COMPANY (US) 1999-02-09 — — US disclosed
US-5824661-A TREATMENT OF OSTEOPOROSIS, OSTEOARTHRITIS, RHEUMATOID ARTHRITIS THE PROCTER & GAMBLE COMPANY (US) 1998-10-20 — — US disclosed
Send feedback